BlackRock Fund Advisors’s MacroGenics MGNX Stock Holding History

BlackRock Fund Advisors’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$30.9M	Buy	1,510,142 +165,850	+12%	+$4.17M	0.01%	1954
2016 Q3	$40.2M	Buy	1,344,292 +69,938	+5%	+$2.08M	0.01%	1720
2016 Q2	$34.4M	Buy	1,274,354 +6,411	+0.5%	+$145K	0.01%	1729
2016 Q1	$23.8M	Buy	1,267,943 +19,873	+2%	+$378K	0.01%	1887
2015 Q4	$38.7M	Sell	1,248,070 -66,001	-5%	-$2M	0.01%	1652
2015 Q3	$28.1M	Buy	1,314,071 +186,396	+17%	+$5.85M	0.01%	1787
2015 Q2	$42.8M	Buy	1,127,675 +218,496	+24%	+$7.18M	0.01%	1624
2015 Q1	$28.5M	Buy	909,179 +26,947	+3%	+$913K	0.01%	1867
2014 Q4	$30.9M	Buy	882,232 +399,696	+83%	+$9.96M	0.01%	1800
2014 Q3	$10.1M	Sell	482,536 -10,206	-2%	-$211K	﹤0.01%	2346
2014 Q2	$10.7M	Buy	492,742 +317,984	+182%	+$6.68M	﹤0.01%	2375
2014 Q1	$4.86M	Buy	174,758 +17,330	+11%	+$612K	﹤0.01%	2834
2013 Q4	$4.32M	Buy	+157,428	New	+$4.12M	﹤0.01%	2913

Other funds holding MGNX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

BRC

Blue Ridge Capital New York $215M AUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

IVM

InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

BlackRock Fund Advisors's MGNX Position: Q4 2016 in Review

BlackRock Fund Advisors increased its MacroGenics (MGNX) stake by 12% in Q4 2016, buying an estimated $4.17M and bringing the position to 1,510,142 shares worth $30.9M. The position accounts for 0.01% of the portfolio, ranked #1954.

BlackRock Fund Advisors first reported a position in MGNX in Q4 2013 and has held it in 13 quarters since. The position peaked at $42.8M in Q2 2015. 131 funds tracked by Wall St. Rank hold MGNX as of Q4 2016.

BlackRock Fund Advisors held 1,510,142 shares of MacroGenics worth $30.9M as of Q4 2016.
BlackRock Fund Advisors bought 165,850 MacroGenics shares in Q4 2016, an estimated $4.17M.
MacroGenics made up 0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #1954 holding.
BlackRock Fund Advisors first reported a position in MacroGenics in Q4 2013 and has held it in 13 quarters since.
BlackRock Fund Advisors's MacroGenics position peaked at $42.8M in Q2 2015.
131 funds tracked by Wall St. Rank held MacroGenics as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.